{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:19:05Z","timestamp":1728965945011},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,14]]},"DOI":"10.7759\/cureus.71478","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T23:23:21Z","timestamp":1728948201000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Oral Sirolimus Therapy for Adult Orbital Slow-Flow Vascular Malformations: A Volumetric Evaluation"],"prefix":"10.7759","author":[{"given":"Tadashi","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Terashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.PRS.0000145633.99581.98","article-title":"Periorbital lymphatic malformation: clinical course and management in 42 patients","volume":"115","author":"Greene AK","year":"2005","unstructured":"Greene AK, Burrows PE, Smith L, Mulliken JB. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg. 2005, 115:22-30. 10.1097\/01.PRS.0000145633.99581.98","journal-title":"Plast Reconstr Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill AM","year":"2011","unstructured":"Hammill AM, Wentzel M, Gupta A, et al.. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011, 57:1018-24. 10.1002\/pbc.23124","journal-title":"Pediatr Blood Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2018.12.001","article-title":"Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: a study protocol for an open-label, single-arm, multicenter, prospective study (SILA)","volume":"10","author":"Ozeki M","year":"2019","unstructured":"Ozeki M, Asada R, Saito AM, et al.. Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: a study protocol for an open-label, single-arm, multicenter, prospective study (SILA). Regen Ther. 2019, 10:84-91. 10.1016\/j.reth.2018.12.001","journal-title":"Regen Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2011.08.021","article-title":"Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery","volume":"67","author":"Shen CY","year":"2012","unstructured":"Shen CY, Wu MC, Tyan YS, Ou CH, Chen TY, Wong HF. Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery. Clin Radiol. 2012, 67:182-4. 10.1016\/j.crad.2011.08.021","journal-title":"Clin Radiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.154","article-title":"Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations","volume":"32","author":"Bothra N","year":"2018","unstructured":"Bothra N, Panda L, Sheth J, Tripathy D. Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations. Eye (Lond). 2018, 32:152-5. 10.1038\/eye.2017.154","journal-title":"Eye (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2018.1480636","article-title":"Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations","volume":"38","author":"Hanif AM","year":"2019","unstructured":"Hanif AM, Saunders JA, Hawkins CM, Wojno TH, Kim HJ. Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations. Orbit. 2019, 38:30-6. 10.1080\/01676830.2018.1480636","journal-title":"Orbit"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.6.614","article-title":"Management of orbital lymphangioma using intralesional injection of OK-432","volume":"84","author":"Suzuki Y","year":"2000","unstructured":"Suzuki Y, Obana A, Gohto Y, Miki T, Otuka H, Inoue Y. Management of orbital lymphangioma using intralesional injection of OK-432. Br J Ophthalmol. 2000, 84:614-7. 10.1136\/bjo.84.6.614","journal-title":"Br J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-006-0510-4","article-title":"Intralesional injection of OK-432 for vision-threatening orbital lymphangioma","volume":"245","author":"Yoon JS","year":"2007","unstructured":"Yoon JS, Choi JB, Kim SJ, Lee SY. Intralesional injection of OK-432 for vision-threatening orbital lymphangioma. Graefes Arch Clin Exp Ophthalmol. 2007, 245:1031-5. 10.1007\/s00417-006-0510-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/lary.21927","article-title":"The successful management of diffuse lymphangiomatosis using sirolimus: a case report","volume":"121","author":"Reinglas J","year":"2011","unstructured":"Reinglas J, Ramphal R, Bromwich M. The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope. 2011, 121:1851-4. 10.1002\/lary.21927","journal-title":"Laryngoscope"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000440939","article-title":"Lymphatic malformation in newborns as the first sign of diffuse lymphangiomatosis: successful treatment with sirolimus","volume":"109","author":"Laforgia N","year":"2016","unstructured":"Laforgia N, Schettini F, De Mattia D, Martinelli D, Ladisa G, Favia V. Lymphatic malformation in newborns as the first sign of diffuse lymphangiomatosis: successful treatment with sirolimus. Neonatology. 2016, 109:52-5. 10.1159\/000440939","journal-title":"Neonatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26780","article-title":"Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation","volume":"128","author":"Strychowsky JE","year":"2018","unstructured":"Strychowsky JE, Rahbar R, O'Hare MJ, Irace AL, Padua H, Trenor CC. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation. Laryngoscope. 2018, 128:269-76. 10.1002\/lary.26780","journal-title":"Laryngoscope"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2021.0103","article-title":"Sirolimus in the treatment of microcystic lymphatic malformations: a systematic review","volume":"21","author":"Teng JM","year":"2023","unstructured":"Teng JM, Hammill A, Martini J, Treat J. Sirolimus in the treatment of microcystic lymphatic malformations: a systematic review. Lymphat Res Biol. 2023, 21:101-10. 10.1089\/lrb.2021.0103","journal-title":"Lymphat Res Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001518","article-title":"The use of sirolimus for treatment of orbital lymphatic malformations: a systematic review","volume":"36","author":"Shoji MK","year":"2020","unstructured":"Shoji MK, Shishido S, Freitag SK. The use of sirolimus for treatment of orbital lymphatic malformations: a systematic review. Ophthalmic Plast Reconstr Surg. 2020, 36:215-21. 10.1097\/IOP.0000000000001518","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2018.1436569","article-title":"Sirolimus-induced regression of a large orbital lymphangioma","volume":"38","author":"Lagr\u00e8ze WA","year":"2019","unstructured":"Lagr\u00e8ze WA, Joachimsen L, Gross N, Taschner C, R\u00f6ssler J. Sirolimus-induced regression of a large orbital lymphangioma. Orbit. 2019, 38:79-80. 10.1080\/01676830.2018.1436569","journal-title":"Orbit"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2023.2214938","article-title":"Intraorbital lymphatic-venous malformation in an adult patient: is sirolimus the key?","volume":"43","author":"Ruiz Velasco Santacruz A","year":"2024","unstructured":"Ruiz Velasco Santacruz A, Nieva Pascual I, Cifuentes Canorea P, D\u00edaz Ram\u00edrez S, Pascual Gonz\u00e1lez M. Intraorbital lymphatic-venous malformation in an adult patient: is sirolimus the key?. Orbit. 2024, 43:535-8. 10.1080\/01676830.2023.2214938","journal-title":"Orbit"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-014-9453-2","article-title":"AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation","volume":"18","author":"Boscolo E","year":"2015","unstructured":"Boscolo E, Coma S, Luks VL, Greene AK, Klagsbrun M, Warman ML, Bischoff J. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis. 2015, 18:151-62. 10.1007\/s10456-014-9453-2","journal-title":"Angiogenesis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/305491-efficacy-of-oral-sirolimus-therapy-for-adult-orbital-slow-flow-vascular-malformations-a-volumetric-evaluation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T23:23:23Z","timestamp":1728948203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/305491-efficacy-of-oral-sirolimus-therapy-for-adult-orbital-slow-flow-vascular-malformations-a-volumetric-evaluation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.71478","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,14]]}}}